Bullfrog AI (BFRG) vs Ensysce Biosciences (ENSC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Ensysce Biosciences is the larger company by market cap ($7.0 million vs $6.6 million), about 1.1 times the size. Ensysce Biosciences converts more of its revenue into profit, with a net margin of -200.8% versus -5569.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BFRG | ENSC |
|---|---|---|
| Share price | $0.3556 | $0.36 |
| Market cap | $6.65M | $7.00M |
| 1-day change | -8.84% | -0.17% |
| YTD return | -59.73% | — |
| 1-year return | -58.21% | — |
| EPS (TTM) | $-0.41 | $-7.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $116.67K | $5.07M |
| Revenue growth (YoY) | — | -2.75% |
| Net income (latest FY) | $-6.50M | $-10.18M |
| Gross margin | 18.76% | — |
| Operating margin | -5652.38% | -202.12% |
| Net margin | -5569.61% | -200.85% |
| 52-week high | $1.96 | $1.85 |
| 52-week low | $0.35 | $0.23 |
| Distance from 52-week high | -81.86% | -80.54% |
| Analyst consensus | none | none |
| Avg. price target upside | — | +2191.67% |
| Average volume | 5.38M | 493.43K |
| Shares outstanding | 18.69M | 19.46M |
| Employees | 9 | 8 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Ensysce Biosciences is more profitable, keeping -200.8 cents of every revenue dollar as net income versus -5569.6 cents for Bullfrog AI.
About Bullfrog AI
BFRG stock →Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 9 employees
About Ensysce Biosciences
ENSC stock →Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, designed to release clinically effective drugs only when exposed to specific physiological conditions; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology.
Health Care · Biotechnology: Pharmaceutical Preparations · 8 employees
BFRG vs ENSC FAQ
Which is bigger, Bullfrog AI or Ensysce Biosciences?
Ensysce Biosciences (ENSC) is larger, with a market capitalization of $7.00M compared with $6.65M for Bullfrog AI (BFRG).
Are Bullfrog AI and Ensysce Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.